Skip to content

Safety and efficacy of cardiac output invasive monitoring in elderly patients

Safety and efficacy of pulse-induced contour cardiac output monitoring in elderly patients with coronary artery disease and severe heart failure at coronary care units

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN73335561
Enrollment
191
Registered
2021-07-09
Start date
2016-01-01
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients with severe heart failure Circulatory System Heart failure

Interventions

Between January 2016 and July 2020, 190 elderly patients with severe heart failure were enrolled and assigned randomly (using a random number generator) to the PiCCO group (89 patients) or noninvasive

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Known history of coronary heart disease 2. Orthopnea (inability to lie down) 3. Wet rales in the lungs 4. Edema in the lower extremities 5. Echocardiography showing left ventricular end-diastolic diameter of >50 mm and left ventricular ejection fraction(LVEF) of <50%, or chest X-ray showing pulmonary congestion or edema 6. Type I respiratory failure (partial pressure of oxygen of <50 mm Hg even after oxygen therapy, requiring tracheal intubation and mechanical ventilation after conventional treatments, such as cardiotonic therapy, diuretics, and vasoactive drugs). 7. Aged 65 - 100 years

Exclusion criteria

Exclusion criteria: 1. Heart failure 2. Uncontrolled severe infection, and pulmonary diseases

Design outcomes

Primary

MeasureTime frame
Length of hospital stay measured using patient records at the end of the study

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026